Literature DB >> 22713447

Successful treatment of pyoderma gangrenosum with intravenous immunoglobulins during pregnancy.

Cornelia Erfurt-Berge1, Christine Herbst, Gerold Schuler, Juergen Bauerschmitz.   

Abstract

BACKGROUND: Pyoderma gangrenosum is a rare ulcerative skin disease usually starting with a pustular lesion that rapidly progresses to painful ulcers with undermined violaceous borders. Numerous associated disorders have been described, including inflammatory bowel disease, rheumatologic or hematologic disorders, chronic active hepatitis, and malignancies. The occurrence of pyoderma gangrenosum during pregnancy is uncommon.
OBJECTIVE: We report a case of a patient with an aggravation of preknown pyoderma gangrenosum during pregnancy who was successfully treated with intravenous immunoglobulins.
CONCLUSION: Administration of immunoglobulins represents a safe and effective treatment option for this subset of patients, as demonstrated in the present case.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22713447     DOI: 10.1177/120347541201600314

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  2 in total

1.  Pyoderma gangrenosum in pregnancy successfully treated with infliximab and prednisone.

Authors:  Julia D Stiegler; Catherine T Lucas; Naveed Sami
Journal:  JAAD Case Rep       Date:  2017-08-30

2.  Intravenous immunoglobulin as salvage therapy in refractory pyoderma gangrenosum: report of a case and review of the literature.

Authors:  John Cafardi; Naveed Sami
Journal:  Case Rep Dermatol       Date:  2014-10-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.